Trinity Biotech Plc (TRIB)
0.6072
0.00 (0.00%)
USD |
NASDAQ |
Apr 06, 14:25
Trinity Biotech EPS Diluted (Quarterly) : -0.274 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.0587 |
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.112M |
| Revenue (Quarterly) | 14.25M |
| Total Expenses (Quarterly) | 19.36M |
| Enterprise Value | 127.26M |
| Gross Profit Margin (Quarterly) | 42.72% |
| Profit Margin (Quarterly) | -35.88% |
| Earnings Yield | -386.9% |
| Normalized Earnings Yield | -346.03 |